Table 1.
Demographic and clinical data among three groups (mean ± SD).
| MWoA-DA | MWoA-DI | HC | P-value | |
|---|---|---|---|---|
| (n = 6) | (n = 13) | (n = 13) | ||
| Age (years) | 39.17 ± 10.49 | 31.46 ± 9.03 | 31.85 ± 9.02 | >0.05 |
| Male/female | 1/5 | 3/10 | 4/9 | >0.05 |
| VAS | 7.67 ± 1.03 | 7.00 ± 1.52 | – | |
| SF-MPQ-2 | 11.33 ± 1.75 | 8.77 ± 4.78 | – | |
| MIDAS | 43.83 ± 22.40 | 21.00 ± 14.36 | – | |
| HIT-6 | 66.17 ± 4.26 | 60.46 ± 7.34 | – | |
| Disease duration (years) | 11.00 ± 2.82 | 6.71 ± 6.39 | – | |
| Migraine frequency (days/month) | 4.91 ± 3.58 | 3.23 ± 2.52 | – |
MWoA-DA, migraine without aura patients during attack; MWoA-DI, migraine without aura patients during interictal; HC, healthy controls; VAS, visual analog score; SF-MPQ, Short-Form McGill Pain Questionnaire-2; MIDAS, Migraine Disability Assessment; HIT-6, Headache Impact Test-6; –, not applicable.